Two Fundamentally Different Approaches to GLP-1 Care
~$181–$279/mo Effective Total
- ○ Compounded GLP-1 via telehealth prescription
- ○ Medication: ~$149–$209/mo (dose-tier)
- ○ Noom app subscription: +$32–$70/mo required
- ○ Effective combined: ~$181–$279/mo
- ○ Async clinical communication
- ○ Behavioral psychology app (Noom's strength)
- ⚠ No in-person examination
- ⚠ No physical lab draw on-site
Variable Cost — Often Insurance-Covered Visits
- ✓ In-person physical examination by licensed clinician
- ✓ On-site or ordered labs (HbA1c, lipids, thyroid)
- ✓ Brand-name Wegovy/Zepbound prescription
- ✓ Insurance may cover office visits
- ✓ Long-term provider relationship
- ✓ Access to complete medical history review
- ⚠ Geographic limitation — availability varies
- ⚠ Medication cost may be higher cash-pay
Noom Med's True Monthly Cost
Noom Med — Effective Monthly Total (June 2026)
What Local Weight Loss Clinics Actually Offer
A "local weight loss clinic" can mean several different things depending on where you live — the clinical depth varies significantly by provider type. Understanding what you're actually comparing matters before evaluating cost or convenience.
Obesity Medicine Specialists (Board-Certified)
The gold standard for in-person weight management care. Board-certified obesity medicine physicians conduct comprehensive metabolic evaluations, can prescribe brand-name Wegovy or Zepbound with insurance PA support, and manage complex comorbidities (type 2 diabetes, sleep apnea, cardiovascular disease) alongside GLP-1 therapy. These are the highest-complexity local option but the least widely available.
Primary Care Physician or Internal Medicine Doctor
The most accessible in-person option. PCPs can prescribe Wegovy, Ozempic, Zepbound, and Mounjaro under FDA obesity/diabetes indications. In-person office visits are often covered by insurance (with co-pay). Your PCP has access to your complete medical history and can coordinate GLP-1 with other medications you take. The limitation: PCPs have limited appointment time for complex obesity counseling.
Weight Loss Med Spas or Commercial Clinics
Commercially branded in-person clinics (often branded as "medical weight loss" centers) vary significantly in quality. Some are medically supervised by licensed physicians; others are supervised by nurse practitioners or physician assistants. Compounded GLP-1 is common in this setting. Quality and clinical rigor vary — verify the prescribing provider's credentials and the compounding pharmacy's licensing before enrolling.
Noom Med vs Local Weight Loss Clinic: Criterion Scorecard
When a Local Weight Loss Clinic Beats Both Noom Med and Telehealth
A local in-person clinic is genuinely the best choice — over both Noom Med and platforms like Luma Health — in these specific situations:
If you have complex comorbidities alongside obesity — type 2 diabetes requiring medication adjustment, cardiovascular disease, severe sleep apnea, significant kidney or liver disease — in-person clinical management coordinates GLP-1 therapy with your other medications and conditions in a way async telehealth cannot replicate. A board-certified obesity medicine physician or your PCP is the appropriate primary care partner here.
If your commercial insurance covers in-person obesity medicine visits and brand-name Wegovy or Zepbound prescriptions: in-person care may be the most cost-effective route once your insurance processes the visit and medication costs. A $25–$40 co-pay for an office visit and $25/month for brand Wegovy through the NovoCare savings card with qualifying insurance can cost dramatically less than any telehealth cash-pay option.
If you want lab work ordered and interpreted by a clinician who has examined you — particularly metabolic panels, thyroid function, HbA1c baseline before starting GLP-1 — in-person care provides this comprehensively. Telehealth platforms, including Noom Med and Luma Health, typically require patients to obtain lab work independently.
When Noom Med Beats a Local Clinic
Telehealth wins when geography, wait times, or schedule make in-person care genuinely inaccessible. If you live in a rural area with no obesity medicine specialist within reasonable distance, if your PCP has a months-long wait for new appointments, or if work and family schedules make scheduling in-person visits impractical — Noom Med's async telehealth model provides GLP-1 access that you might not otherwise get at all. The Noom behavioral app is also a genuine differentiator for patients who respond to the Noom methodology and will use the coaching infrastructure consistently.
Who Should Choose What
Choose Noom Med If...
- ○ You respond to the Noom behavioral methodology (food psychology, calorie density) and will use the app daily
- ○ Local weight loss clinic access is limited by geography or wait times
- ○ You want a bundled medication + behavioral app in one subscription
- ○ You're comfortable paying ~$181–$279/mo effective for medication + app combined
Choose Local Clinic If...
- ✓ You have complex comorbidities that need in-person management alongside GLP-1
- ✓ Your insurance covers obesity medicine visits and may cover brand Wegovy
- ✓ You want comprehensive metabolic lab work ordered and interpreted in-person
- ✓ You prefer a face-to-face provider relationship for long-term care
★ Choose Luma Health If...
- ✓ You want telehealth GLP-1 without Noom's mandatory app overhead ($32–$70/mo)
- ✓ You want pharmacy named publicly before paying — VialsRX TX#35264
- ✓ You want $197/mo flat sema (less than Noom Med's combined rate)
- ✓ You want no commitment — cancel anytime, single subscription
Frequently Asked Questions
Is Noom Med or a local weight loss clinic better for GLP-1?
It depends on your specific situation. For patients with complex obesity comorbidities, commercial insurance that covers in-person visits and brand Wegovy, or a preference for face-to-face clinical relationships, a local weight loss clinic or primary care physician is often the better choice — and may be more cost-effective when insurance is applied. For patients where local access is limited, where in-person scheduling is impractical, or where cost on a cash-pay basis is the primary constraint, Noom Med's telehealth access is the more practical option. The Noom behavioral app is a genuine differentiator for patients who will actively use it.
Can my primary care doctor prescribe GLP-1 for weight loss?
Yes. Primary care physicians and internal medicine doctors can prescribe Wegovy (semaglutide), Ozempic (semaglutide for diabetes), Zepbound (tirzepatide), and Mounjaro (tirzepatide for diabetes) under FDA-approved indications. If you have commercial insurance and a PCP relationship, this may be the most efficient path — your PCP can initiate prior authorization with your insurer and, with the NovoCare or Eli Lilly savings card, reduce your monthly medication cost to approximately $25. This approach combines clinical depth (your PCP knows your full medical history) with potential insurance coverage — making it competitive with or cheaper than any telehealth cash-pay option for eligible patients.
Does Noom Med require the Noom app?
Yes. Noom Med's GLP-1 medication program is bundled with a Noom app subscription — the app is not optional. The app costs approximately $32–$70/month depending on your plan tier. The effective monthly total for Noom Med is therefore the medication rate plus the app rate: approximately $181–$279/month combined. Patients who won't use the Noom app's behavioral tools consistently are paying for unused services. If you want compounded GLP-1 without an app subscription, platforms like Luma Health ($197/month flat for semaglutide) offer the medication without behavioral app overhead.
Does insurance cover Noom Med?
No — Noom Med's compounded GLP-1 program is cash-pay only. Insurance does not cover compounded semaglutide or tirzepatide from Noom Med or any other telehealth compounding platform. Insurance coverage is possible for brand-name Wegovy or Zepbound through a prior authorization process — but this requires a prescription from a licensed provider, which can be initiated through your PCP or an in-person specialist, not through Noom Med's standard compounded pathway. If insurance coverage is your goal, in-person care through your PCP or a specialist is the appropriate pathway.
How does Luma Health compare to Noom Med?
Luma Health offers compounded semaglutide at $197/month flat — less than Noom Med's effective combined total of $181–$279/month at most dose tiers, because Luma Health doesn't charge a mandatory app subscription. VialsRX (TX #35264) is publicly named and independently verifiable at pharmacy.texas.gov. No contracts, cancel anytime. Luma Health does not include behavioral coaching — the Noom app's psychology methodology is a genuine differentiator for patients who respond to it. If you won't use behavioral app coaching, Luma Health costs less and provides the same compounded GLP-1 medication with greater pharmacy transparency.
What is the cheapest way to get GLP-1 for weight loss in 2026?
The cheapest option depends on your insurance status. With commercial insurance that covers Wegovy/Zepbound for obesity and a qualifying prior authorization: brand-name medication via your PCP or an in-person specialist plus the NovoCare/Eli Lilly savings card can cost ~$25/month — the lowest available price. Without applicable insurance: Henry Meds' annual billing plan for compounded semaglutide (~$145/month) or tirzepatide (~$179/month) is the lowest cash-pay rate. Luma Health's $197/month flat sema or $297/month flat tirz is the best combination of flat-rate pricing and named pharmacy transparency without an annual commitment. See our cheapest GLP-1 providers ranked guide for the full comparison.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed
- Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). N Engl J Med. 2023;389:2221–2232. PubMed
- FDA. Human Drug Compounding — Section 503A. FDA.gov
- American Board of Obesity Medicine. abom.org
- NovoCare. Wegovy Savings Program. novocare.com
- Noom. Noom Med Program. noom.com/med
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov